{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:elamipretide-barth-syndrome-study-updated:v1","objectPathId":"elamipretide-barth-syndrome-study-updated-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/elamipretide-barth-syndrome-study-updated/","json":"https://peptidescanner.com/evidence/v1/objects/elamipretide-barth-syndrome-study-updated-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/elamipretide-barth-syndrome-study-updated-v1.md"},"story":{"slug":"elamipretide-barth-syndrome-study-updated","version":1,"domain":"Clinical trials","dateInSource":"2026-07-13","sourceCheckedAt":"2026-07-22","publishedAt":"2026-07-22","peptideSlugs":["elamipretide"],"peptides":[{"slug":"elamipretide","url":"https://peptidescanner.com/peptides/elamipretide/"}]},"claims":[{"id":"headline","text":"Elamipretide Barth syndrome study record updated","sourceIds":["ctg-nct07531251-v4"]},{"id":"summary","text":"ClinicalTrials.gov lists a recruiting Elamipretide study sponsored by Stealth BioTherapeutics Inc.","sourceIds":["ctg-nct07531251-v4"]},{"id":"paragraph-1","text":"ClinicalTrials.gov lists the NCT07531251 record under Stealth BioTherapeutics Inc. Its overall recruitment status was shown as recruiting when PeptideScanner reviewed the record.","sourceIds":["ctg-nct07531251-v4"]},{"id":"paragraph-2","text":"The registry shows 2026-07-13 as its latest posted update date. This update reports the registry record and does not establish safety, effectiveness, or a trial outcome.","sourceIds":["ctg-nct07531251-v4"]}],"sources":[{"id":"ctg-nct07531251-v4","name":"ClinicalTrials.gov","sourceClass":"A","title":"4TAZPower: Elamipretide in Participants With Barth Syndrome · record history version 4 · last update posted 2026-07-13","url":"https://clinicaltrials.gov/study/NCT07531251?a=4&tab=history"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"9a0cbdb15e46d40c8dff732d988d048e8a993bbc88d4d2b9be57b35fe704637c"},"integrity":{"algorithm":"sha256","contentSha256":"40254a98bebcc0722b290543988272049b41ec52ba60c3d6ed581bce0dbec664"}}